Workhorse Group names Jody Davis as new CFO

Workhorse Group Inc. (NASDAQ: WKHS) announced the appointment of Jody Davis as Chief Financial Officer, replacing Bob Ginnan, who is retiring after serving in the role since January 2022.

Davis brings approximately 15 years of finance leadership experience across manufacturing, energy storage, aerospace, and technology sectors. Most recently, he served as Vice President of Strategic Finance at Unimacts, where he led financing initiatives across multiple entities within a complex capital structure.

Prior to that role, Davis served as CFO of Evio, formerly EOS Aircraft Inc., a hybrid-electric regional aircraft program, where he led the strategic repositioning of the business to Montreal, Canada as part of an Industrial and Technological Benefits partnership with Boeing Canada. He was also a founding team member and CFO of Our Next Energy Inc., a Michigan-based battery company, where he helped scale the business from pre-seed stage to production with approximately 500 employees.

"Jody is a company-builder who has deep and direct experience in numerous areas that are critical to Workhorse at this stage in our journey," said Scott Griffith, CEO of Workhorse. "His experience raising later-stage growth capital combined with experience developing relationships with analysts and investors will be a strong addition to the Workhorse leadership team."

Griffith also acknowledged the departing CFO: "I want to thank Bob for his years of leadership and tireless work, including his most recent efforts to assist with finalizing and closing the Workhorse-Motiv merger and his efforts to lead several key aspects of integration."

Workhorse, headquartered in the Detroit area with a manufacturing facility in Union City, Indiana, produces electric trucks, step vans, shuttles, and buses. The company stated that Davis's priorities will include securing growth capital, building relationships with institutional investors, and reducing costs on its W56 and next-generation Class 5–6 platforms.

You May Also Be Interested In

• Matinas BioPharma to merge with GH Power, sell drug unit to Azurity
• Brown-Forman CEO Lawson Whiting to retire after nearly 30 years
• BioMarin completes acquisition of Amicus Therapeutics